Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Alessandro Armuzzi and Alfredo Papa.
Alessandro Armuzzi
Connection Strength
0.608
Alfredo Papa
  1. Impact of COVID-19 pandemic on the daily management of biotechnological therapy in inflammatory bowel disease patients: Reorganisational response in a high-volume Italian inflammatory bowel disease centre. United European Gastroenterol J. 2020 08; 8(7):775-781.
    View in: PubMed
    Score: 0.221
  2. Harmful Effects and Potential Benefits of Anti-Tumor Necrosis Factor (TNF)-a on the Liver. Int J Mol Sci. 2018 Jul 27; 19(8).
    View in: PubMed
    Score: 0.195
  3. The impact of COVID-19 pandemic on IBD endoscopic procedures in a high-volume IBD Center. Endosc Int Open. 2020 Jul; 8(7):E980-E984.
    View in: PubMed
    Score: 0.056
  4. Body mass index influences infliximab post-infusion levels and correlates with prospective loss of response to the drug in a cohort of inflammatory bowel disease patients under maintenance therapy with Infliximab. PLoS One. 2017; 12(10):e0186575.
    View in: PubMed
    Score: 0.046
  5. Effectiveness of Mesalazine, Thiopurines and Tumour Necrosis Factor Antagonists in Preventing Post-Operative Crohn's Disease Recurrence in a Real-Life Setting. Digestion. 2017; 96(3):166-172.
    View in: PubMed
    Score: 0.046
  6. Training Programs on Endoscopic Scoring Systems for Inflammatory Bowel Disease Lead to a Significant Increase in Interobserver Agreement Among Community Gastroenterologists. J Crohns Colitis. 2017 05 01; 11(5):556-561.
    View in: PubMed
    Score: 0.045
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.